The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
Condition(s):Major Depressive DisorderLast Updated:June 16, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:June 16, 2020Completed
Condition(s):Covid19; Covid19 Drug Treatment; Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV2 InfectionLast Updated:January 31, 2023Recruiting
Condition(s):Syndrome XLast Updated:March 4, 2020Unknown status
Condition(s):HIV Infections; DepressionLast Updated:November 15, 2013Completed
Condition(s):Depression; Relapsing-remitting Multiple SclerosisLast Updated:September 25, 2014Terminated
Condition(s):Geriatric Depression; Cognitive ImpairmentLast Updated:January 5, 2024Recruiting
Condition(s):Major Depressive DisorderLast Updated:August 12, 2022Unknown status
Condition(s):Healthy VolunteerLast Updated:February 10, 2014Completed
Condition(s):Depressive DisorderLast Updated:June 7, 2023Recruiting
Condition(s):DepressionLast Updated:November 8, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.